168 Participants Needed

Cognitive Behavioral Therapy for Insomnia

(CBTBI Trial)

AG
AB
Overseen ByAnice Byrd
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Noctem, LLC
Must be taking: Psychotropic, Hypnotic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The objective of the study is to conduct a randomized controlled trial of Cognitive Behavioral Therapy for Insomnia (CBT-I) in a sample of active-duty sailors with a history of traumatic brain injury (TBI). The investigators will test the impact of CBT-I on insomnia symptoms as well as post-concussive symptoms, psychological symptoms, and neurocognitive functioning in comparison to treatment as usual. The investigators will also compare the effectiveness of traditional in-person CBT-I and CBT-I delivered via a clinician-supervised digital health platform, Clinician Operated Assistive Sleep Technology (COAST) in comparison to treatment as usual on symptoms of insomnia, post-concussive symptoms, neurocognitive functioning, and psychological health. Participants will be assessed at baseline, post-treatment, and 3 months later.

Will I have to stop taking my current medications?

You can continue taking your current psychotropic and hypnotic medications if you have been on the same dose for at least 8 weeks and there are no expected changes during the trial. The study will track any medication changes, but you don't need to stop taking them.

What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia (CBT-I)?

Research shows that CBT-I is effective for improving sleep quality and reducing the need for sleep medication in people with both primary insomnia and insomnia related to other health issues. It is considered the first choice for treating chronic insomnia.12345

Is Cognitive Behavioral Therapy for Insomnia (CBT-I) safe for humans?

Cognitive Behavioral Therapy for Insomnia (CBT-I) is considered safe and is recommended as the first-line treatment for insomnia, as it does not have the risks associated with sleeping medications.16789

How is CBT-I treatment different from other treatments for insomnia?

CBT-I (Cognitive Behavioral Therapy for Insomnia) is unique because it is a non-drug treatment that focuses on changing sleep habits and behaviors, making it the first-line treatment for insomnia, even when it occurs alongside other health issues. Unlike medications, it addresses the root causes of insomnia and can be effective in a single session or over a longer period, depending on the individual's needs.16101112

Eligibility Criteria

This trial is for active-duty sailors who have experienced a traumatic brain injury (TBI) and are struggling with insomnia. Participants should be currently serving, have a history of TBI, and suffer from sleep problems. Details on specific inclusion or exclusion criteria were not provided.

Inclusion Criteria

Active duty Sailors and activated Reservist Sailors
History of TBI confirmed by study evaluators
Own a smart device for using the COAST app
See 3 more

Exclusion Criteria

Inability to comprehend or read English
Serious mental health diagnosis such as bipolar disorder or psychosis, or seizure disorder
Potential alcohol use disorder
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Cognitive Behavioral Therapy for Insomnia (CBT-I) either in-person or via the COAST platform for 6 weeks

6 weeks
Weekly sessions

Post-treatment Assessment

Participants are assessed within 10 days after the treatment phase to evaluate insomnia, post-concussive symptoms, and psychological health

1-2 weeks

Follow-up

Participants are monitored for safety and effectiveness 3 months after treatment

3 months
1 visit (in-person or virtual)

Treatment Details

Interventions

  • Cognitive Behavioral Therapy for Insomnia (CBT-I)
Trial Overview The study compares Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered in person versus through a digital platform called COAST against usual treatment. It aims to see how each method affects sleep issues, post-concussive symptoms, thinking abilities, and mental health.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: In-Person CBT-IExperimental Treatment1 Intervention
Group II: CBT-I via COASTExperimental Treatment1 Intervention
Group III: Treatment as UsualActive Control1 Intervention
Participants will receive only TBI-related interventions. No insomnia-specific interventions will be provided.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Noctem, LLC

Lead Sponsor

Trials
3
Recruited
370+

Naval Health Research Center

Collaborator

Trials
21
Recruited
177,000+

United States Naval Medical Center, San Diego

Collaborator

Trials
110
Recruited
24,200+

Findings from Research

Cognitive behavioral therapy for insomnia (CBT-I) is recognized as the first-line treatment for both uncomplicated insomnia and insomnia associated with other chronic disorders, demonstrating its broad efficacy.
This review aims to summarize efficacy data across various clinical and demographic factors and to outline future research and implementation strategies for CBT-I, highlighting its importance in treating sleep disorders.
We know CBT-I works, now what?Muench, A., Vargas, I., Grandner, MA., et al.[2022]
Cognitive Behavioral Therapy for Insomnia (CBT-I) significantly improved sleep parameters in 51 patients with chronic insomnia, including reductions in sleep latency, number of awakenings, and overall sleep quality, with effects lasting for at least 3 months after treatment.
Post-treatment, patients with insomnia showed no significant differences in sleep quality and mental health symptoms compared to healthy controls, indicating that CBT-I can effectively restore normal sleep patterns and improve overall functioning.
[Cognitive behavioral therapy for chronic insomnia].Fornal-Pawłowska, M., Szelenberger, W.[2018]
Cognitive Behavioral Therapy for Insomnia (CBT-I) significantly improved sleep quality, sleep onset, and sleep efficiency in 76 patients with primary insomnia over a 6-week group course in a clinical setting.
CBT-I also led to reductions in medication use and improvements in patients' overall health and cognitive functioning, highlighting its effectiveness beyond just sleep improvement.
[Cognitive-behavioural therapy for primary insomnia: effectiveness in a clinical setting].Van Houdenhove, L., Buyse, B., Gabriels, L., et al.[2018]

References

We know CBT-I works, now what? [2022]
[Cognitive behavioral therapy for chronic insomnia]. [2018]
[Cognitive-behavioural therapy for primary insomnia: effectiveness in a clinical setting]. [2018]
Delivering Cognitive Behavioral Therapy for Insomnia in the Real World: Considerations and Controversies. [2019]
Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. [2022]
Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. [2022]
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. [2022]
Who is a candidate for cognitive-behavioral therapy for insomnia? [2022]
"Sign Me Up, I'm Ready!": Helping Patients Prescribed Sleeping Medication Engage with Cognitive Behavioral Therapy for Insomnia (CBT-I). [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Effectiveness of abbreviated CBT for insomnia in psychiatric outpatients: sleep and depression outcomes. [2022]
Improvement of Insomnia Symptoms following a Single 4-Hour CBT-I Workshop. [2023]
Cognitive behavioral therapy for chronic insomnia in occupational health services: analyses of outcomes up to 24 months post-treatment. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security